Concise Review: Current Status of Three-Dimensional Organoids as Preclinical Models.

Concise Review: Current Status of Three-Dimensional Organoids as Preclinical Models.
复制标题

DOI:
10.1002/stem.2852
复制
发表时间:
2018-09
期刊:
Stem cells (Dayton, Ohio)
影响因子:
--
通讯作者:
Batra SK
Batra SK
中科院分区:
其他
文献类型:
--
作者:
Kaushik G;Ponnusamy MP;Batra SK

文献摘要

参考文献

被引文献

相似文献

三维(3D)培养利用一些细胞在基质中自我组织的特性,并产生可以被编程为代表器官或病理的结构。类器官培养是源组织(从细胞到组织片段)在几乎类似生理环境的支持基质和专门介质中的3D培养。根据来源组织、生长因子和提供的抑制剂,类器官可以被编程以概括系统的生物学和病理进展。类器官在基因上是稳定的,并且是可顺从的,这使它们成为研究组织稳态和癌症的非常合适的工具。在这篇综述中,我们着重从已发表的文献中提供最近的技术进展,以有效地利用类器官作为疾病建模和治疗的工具。此外,我们讨论了干细胞生物学原理用于产生多个类器官及其特点,并简要介绍了方法。本综述的一个主要主题是将类器官应用于研究不同癌症的疾病进展和药物反应。我们还讨论了发达的3D文化的缺点、局限性和优势,以及该方法背后的基本原理。
Three-dimensional (3D) cultures use the property of some cells to self-organize in matrices and generate structures that can be programmed to represent an organ or a pathology. Organoid cultures are the 3D cultivation of source tissue (ranging from cells to tissue fragments) in a support matrix and specialized media that nearly resembles the physiological environment. Depending on the source tissue, growth factors, and inhibitors provided, organoids can be programmed to recapitulate the biology of a system and progression of pathology. Organoids are genetically stable, and genetically amenable, making them very suitable tools to study tissue homeostasis and cancer. In this review, we focus on providing recent technical advances from published literature to efficiently use organoids as a tool for disease modeling and therapeutics. Also, we discuss stem cell biology principles utilized to generate multiple organoids and their characteristics, with a brief description of methodology. A major theme of this review is to expand organoid applications to the study disease progression and drug response in different cancers. We also discuss shortcomings, limitations, and advantages of developed 3D cultures, with the rationale behind the methodology.
DOI: 10.1371/journal.pone.0133238
发表时间: 2015
期刊: PloS one
影响因子: 3.7
作者:
Calderon-Gierszal EL;Prins GS
通讯作者: Prins GS
DOI: 10.18632/oncotarget.7092
发表时间: 2016-02-23
期刊: Oncotarget
影响因子: --
作者:
Chen Z;Sun M;Yuan Q;Niu M;Yao C;Hou J;Wang H;Wen L;Liu Y;Li Z;He Z
通讯作者: He Z
DOI: 10.1016/j.jcf.2004.05.010
发表时间: 2004-08-01
期刊: Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society
影响因子: --
作者:
Bals, Robert;Beisswenger, Christoph;Chinet, Thierry
通讯作者: Chinet, Thierry
DOI: 10.1038/nm.3973
发表时间: 2015-11-01
期刊: NATURE MEDICINE
影响因子: 82.9
作者:
Huang, Ling;Holtzinger, Audrey;Muthuswamy, Senthil K.
通讯作者: Muthuswamy, Senthil K.
DOI: 10.1073/pnas.0801866105
发表时间: 2008-07-15
影响因子: 11.1
作者:
Du, Yanan;Lo, Edward;Khademhosseini, Ali
通讯作者: Khademhosseini, Ali